Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer

Дата публикации: 01-01-2025 00:00:00

This randomized clinical trial evaluates the efficacy and safety of first-line toripalimab vs placebo plus etoposide and platinum-based chemotherapy for treating patients with extensive-stage small cell lung cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Individualized Stereotactic Ablative Radiotherapy for Lung Tumors	0	6.6	01-11-2023
2	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer	0	18.85	30-07-2026
3	PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression	0	15.58	01-07-2026
4	Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma	0	5.96	30-07-2026
5	Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients with Advanced NSCLC with EGFR Exon 20 Insertions	0	5	23-06-2026
6	Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC	0	5	30-06-2026
7	EMA Recommends Extension of Therapeutic Indications for Serplulimab	0	13.88	31-07-2026
8	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
9	Ensartinib Improves DFS Outcomes in Patients with ALK-positive, Completely Resected Stage II to IIIB NSCLC	0	15	27-07-2026
10	Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma	0	4.44	13-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.28. Источник: archderm.jamanetwork.com.